Discovery of a Non-Nucleoside SETD2 Methyltransferase Inhibitor against Acute Myeloid Leukemia

Histone methyltransferases (HMTs) have attracted considerable attention as potential targets for pharmaceutical intervention in various malignant diseases. These enzymes are known for introducing methyl marks at specific locations of histone proteins, creating a complex system that regulates epigene...

Full description

Bibliographic Details
Main Authors: Dávid Bajusz, Zsolt Bognár, Jessica Ebner, Florian Grebien, György M. Keserű
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
AML
Online Access:https://www.mdpi.com/1422-0067/22/18/10055